Literature DB >> 18974080

Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens.

C Lloyd1, D Lowe, B Edwards, F Welsh, T Dilks, C Hardman, T Vaughan.   

Abstract

A large 1.29 x 10(11) antibody fragment library, based upon variable (V) genes isolated from human B-cells from 160 donors has been constructed and its performance measured against a panel of 28 different clinically relevant antigens. Over 5000 different target-specific antibodies were isolated to the 28 antigens with 3340 identified as modulating the biological function (e.g. antagonism, agonism) of the target antigen. This represents an average of approximately 120 different functionally active antibodies per target. Analysis of a sample of >800 antibodies from the unselected library indicates V gene usage is representative of the human immune system with no strong bias towards any particular V(H)-V(L) pairing. Germline diversity is broad with 45/49 functional V(H) germlines and 28/30 V(lambda) and 30/35 V(kappa) light-chain germlines represented in the sample. The number of functional V(H) germlines and V(kappa) light-chain germlines present is increased to 48/49 and 31/35, respectively, when selected V gene usage is included in the analysis. However, following selection on the antigen panel, V(H)1-V(lambda)1 germline family pairings are preferentially enriched and represent a remarkable 25% of the antigen-specific selected repertoire.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974080     DOI: 10.1093/protein/gzn058

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  55 in total

1.  Sequencing antibody repertoires: the next generation.

Authors:  Nicolas Fischer
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  VH-VL orientation prediction for antibody humanization candidate selection: A case study.

Authors:  Alexander Bujotzek; Florian Lipsmeier; Seth F Harris; Jörg Benz; Andreas Kuglstatter; Guy Georges
Journal:  MAbs       Date:  2016       Impact factor: 5.857

3.  Selecting antagonistic antibodies that control differentiation through inducible expression in embryonic stem cells.

Authors:  Anna N Melidoni; Michael R Dyson; Sam Wormald; John McCafferty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

4.  Large scale production of phage antibody libraries using a bioreactor.

Authors:  Fortunato Ferrara; Chang-Yub Kim; Leslie A Naranjo; Andrew R M Bradbury
Journal:  MAbs       Date:  2015       Impact factor: 5.857

5.  Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.

Authors:  Christine J Rossant; Danielle Carroll; Ling Huang; John Elvin; Frances Neal; Edward Walker; Joris J Benschop; Eldar E Kim; Simon T Barry; Tristan J Vaughan
Journal:  MAbs       Date:  2014       Impact factor: 5.857

6.  A high-throughput platform for population reformatting and mammalian expression of phage display libraries to enable functional screening as full-length IgG.

Authors:  Xiaodong Xiao; Julie A Douthwaite; Yan Chen; Ben Kemp; Sara Kidd; Jennifer Percival-Alwyn; Alison Smith; Kate Goode; Bonnie Swerdlow; David Lowe; Herren Wu; William F Dall'Acqua; Partha S Chowdhury
Journal:  MAbs       Date:  2017-06-14       Impact factor: 5.857

7.  Next-generation antibody discovery platforms.

Authors:  Gary Hardiman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

8.  Construction of a rationally designed antibody platform for sequencing-assisted selection.

Authors:  H Benjamin Larman; George Jing Xu; Natalya N Pavlova; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-11       Impact factor: 11.205

9.  A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.

Authors:  Thomas Tiller; Ingrid Schuster; Dorothée Deppe; Katja Siegers; Ralf Strohner; Tanja Herrmann; Marion Berenguer; Dominique Poujol; Jennifer Stehle; Yvonne Stark; Martin Heßling; Daniela Daubert; Karin Felderer; Stefan Kaden; Johanna Kölln; Markus Enzelberger; Stefanie Urlinger
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

10.  A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).

Authors:  Ronald S Boshuizen; Catherine Marsden; Johan Turkstra; Christine J Rossant; Jerry Slootstra; Clive Copley; Klaus Schwamborn
Journal:  MAbs       Date:  2014       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.